All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only ...

Building on that foundation, the GO Genomic Report generated through this workflow will now include a direct link to the WeTrials platform. With a single click, clinicians can move from a patient's ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE ...

Avik Pal, Founder and CEO of CliniOps, a technology and data company with multiple patents to digitize global clinical trials. When Michael J. Fox and Stephen Hawking publicly shared their personal ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

Open communication in clinical trials helps prevent patients from feeling overwhelmed by complex details and enhances understanding. Initial discussions focus on general trial participation before ...

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

What happens to a patient after I refer them to a clinical trial? Do they leave my practice? Referring patients to a clinical trial is similar to referring them to a specialist. They remain your ...

DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence-based Clinical Trial Solutions for Patient Matching - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering ...

The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...

Rare Patient Voice is sharing new results from a survey conducted amongst their patient participant community on clinical trial co-design, to bring clarity to why and how the patient voice should be ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-tar ...